95 results
DEFM14A
ISEE
IVERIC bio Inc
5 Jun 23
Proxy related to merger
8:54am
.
Centerview assumed, without independent verification or any responsibility therefor, the accuracy and completeness of the financial, legal … of Centerview’s written opinion, and Centerview does not have any obligation or responsibility to update, revise or reaffirm its opinion based on circumstances
PREM14A
ISEE
IVERIC bio Inc
23 May 23
Preliminary proxy related to merger
6:49am
.
Centerview assumed, without independent verification or any responsibility therefor, the accuracy and completeness of the financial, legal, regulatory, tax … written opinion, and Centerview does not have any obligation or responsibility to update, revise or reaffirm its opinion based on circumstances
DEFA14A
EX-2.1
ISEE
IVERIC bio Inc
1 May 23
Additional proxy soliciting materials
7:05am
or a committee, institutional, regional, national, or supranational), constituted of medical professionals and non-medical members, whose responsibility
8-K
EX-2.1
ISEE
IVERIC bio Inc
1 May 23
Astellas Enters into Definitive Agreement
7:02am
or a committee, institutional, regional, national, or supranational), constituted of medical professionals and non-medical members, whose responsibility
8-K
EX-1.1
evu29 fh4d1u
5 Dec 22
Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock
7:45am
424B5
108xsxu nd15t
1 Dec 22
Prospectus supplement for primary offering
4:02pm
424B5
oabwkp5s
30 Nov 22
Prospectus supplement for primary offering
4:11pm
8-K
EX-1.1
9vbdl5i m0r
25 Oct 21
Iveric Bio Announces Pricing of Upsized Public Offering of Common Stock
4:01pm
424B5
jbnog4y 3zwaele41ddp
22 Oct 21
Prospectus supplement for primary offering
4:02pm